Quanterix (NASDAQ:QTRX – Get Free Report) will likely be releasing its earnings data before the market opens on Thursday, March 6th. Analysts expect Quanterix to post earnings of ($0.27) per share and revenue of $34.93 million for the quarter.
Quanterix (NASDAQ:QTRX – Get Free Report) last announced its earnings results on Monday, December 23rd. The company reported ($0.22) EPS for the quarter. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. On average, analysts expect Quanterix to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Quanterix Stock Performance
Shares of NASDAQ:QTRX opened at $7.09 on Tuesday. The business’s fifty day moving average price is $9.30 and its two-hundred day moving average price is $11.41. The stock has a market cap of $273.14 million, a PE ratio of -6.69 and a beta of 1.33. Quanterix has a one year low of $7.08 and a one year high of $29.70.
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on QTRX
About Quanterix
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Recommended Stories
- Five stocks we like better than Quanterix
- 3 Stocks to Consider Buying in October
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What is the Euro STOXX 50 Index?
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.